These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Particulate inspection of parenteral products: from biophysics to automation. Knapp JZ; Kushner HK J Parenter Sci Technol; 1982; 36(3):121-7. PubMed ID: 7097455 [No Abstract] [Full Text] [Related]
23. Prediction of drug particle size and content uniformity in low-dose solid dosage forms. Huang CY; Sherry Ku M Int J Pharm; 2010 Jan; 383(1-2):70-80. PubMed ID: 19747967 [TBL] [Abstract][Full Text] [Related]
24. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits. Parkins DA; Taylor AJ Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122 [TBL] [Abstract][Full Text] [Related]
25. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters. Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100 [TBL] [Abstract][Full Text] [Related]
26. Cleaning Validation: Complete Guide for Health - Based Approach in Chemical Cross - Contamination Risk Assessment. Tanyous JN PDA J Pharm Sci Technol; 2019; 73(2):204-210. PubMed ID: 30361288 [TBL] [Abstract][Full Text] [Related]
27. Analysis of Particulate Matter in Liquid-Finished Dosage Forms. Duchek J; Havasi B PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612 [TBL] [Abstract][Full Text] [Related]
28. Charting and Evaluation of Environmental Microbial Monitoring Data. Bar R PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105 [TBL] [Abstract][Full Text] [Related]
35. A new coincidence model for single particle counters, Part I: Theory and experimental verification. Knapp JZ; Abramson LR J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513 [TBL] [Abstract][Full Text] [Related]
36. Letter: Particulate contamination--let's solve the problem. Bailey DE Am J Hosp Pharm; 1974 Jan; 31(1):30. PubMed ID: 4810163 [No Abstract] [Full Text] [Related]
37. Method for determination and element analysis of particulate contamination in injectable solutions. Winding O; Holma B Am J Hosp Pharm; 1976 Nov; 33(11):1154-9. PubMed ID: 998621 [TBL] [Abstract][Full Text] [Related]
38. Inorganic particle content of foods and drugs. Eisenberg WV Environ Health Perspect; 1974 Dec; 9():183-91. PubMed ID: 4377870 [TBL] [Abstract][Full Text] [Related]
39. Industry perspective on the medical risk of visible particles in injectable drug products. Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720 [No Abstract] [Full Text] [Related]